Minimally invasive surgeries are intended to be performed with minimal incision made in the patient’s body and ensure quick recovery along with minimal duration of hospital stay. Minimally invasive surgeries are now increasingly gaining importance and preference over conventional invasive surgeries due to the multiple benefits associated with these surgeries including reduced recovery time, minima patient trauma, reduced duration of hospital stay, and hence, the overall cost of treatment. The market is also expected to grow owing to rising prevalence of various diseases such as cancer, for which minimally invasive surgery is a treatment option. This would undoubtedly enhance the growth of minimally invasive surgery market. The devices utilized for performing minimally invasive surgeries mainly include ablation devices, electrosurgical devices, medical robotic systems and endoscopy devices.
This report studies the global minimally invasive surgery (MIS) market from three perspectives, namely, types of devices used in performing these surgeries, various types of surgeries performed and the major geographic markets. The global market for MIS has been segmented into three main categories of devices that include surgical devices, monitoring and visualization devices, and endoscopy devices. Surgical devices are further classified as ablation devices, electrosurgical devices, and medical robotic systems. Similarly, the monitoring and visualization devices market has also been segmented into MRI equipment, CT scanners, X-ray devices, ultrasound equipment and other (PET and SPECT scanners, and combination devices such as PET/CT, PET/MRI, SPECT/CT, and SPECT/MRI). The market for this segment has been extensively analyzed based on number of installed base of these imaging modalities, reimbursement scenario and cost. The market size and forecast in terms of USD million for each product type has been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for each segment
The various types of minimally invasive surgeries performed have also been provided in the report. The global market for minimally invasive surgery has been segmented into orthopedic surgery (spinal surgery and joint replacement surgery), cosmetic surgery, breast surgery, vascular surgery, thoracic surgery, gynecological surgery, bariatric surgery, cardiac surgery, gastrointestinal surgery and urological surgery. Geographically, the report segments the global market into four main regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market for all the aforementioned segments has been extensively analyzed based on number of surgeries, number of diseases, technological advancements in surgical equipment, reimbursement scenario and cost. The market size and forecast in terms of USD million for each product type has been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for each segment.
The market overview section of the report discusses the market dynamics with respect to market drivers, restraints and opportunities. This section also covers a market attractiveness analysis (by geography) and Porter’s five forces analysis for the global minimally invasive surgery market. Market share (%) for the major players operating in this market has also been provided for the year 2012, followed by a list of recommendations for the existing and new players to enter and enhance their market shares and enter the market respectively. The report concludes with the company profiles of key players operating in various segments of the market. Each company profile includes the business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Some of the prominent players in the minimally invasive surgery market that have been profiled in this report include Intuitive Surgical, Inc., GE Healthcare, Philips Healthcare, Siemens Healthcare, Medtronic, Inc., Stryker Corporation, Biomet, Inc. and DePuy Synthes, Inc.